Philippe M. R. Guinot

Director/Board Member at

BioVex, Inc.

Health Technology

Commercial Services

Process Industries

Profile

Philippe M.
R.
Guinot is currently a Director at BioVex, Inc. He previously held positions as Chairman at iTeos Therapeutics SA, Director at Diatos SA, Director at BioVex Group, Inc., Director at Xention Pharma Ltd., Director-Supervisory Board at PanGenetics BV, Director at Cytheris SA, Director at Amsterdam Molecular Therapeutics (AMT) Holding NV, Director at Era Biotech SA, Head-Drug Development Group at Beaufour Ipsen Pharma SAS, and Member-Supervisory Board at METabolic EXplorer SA. He was also a Senior Partner at Omnes Capital SAS from 2010 to 2011.

Philippe M. R. Guinot active positions

Companies	Position	Start
BioVex, Inc. BioVex, Inc. Pharmaceuticals: MajorHealth Technology Develops vaccines for the treatment of cancer and the prevention of chronic infectious diseases	Director/Board Member	14/05/2009

All active positions of Philippe M. R. Guinot

Former positions of Philippe M. R. Guinot

Companies	Position	End
iTeos Therapeutics SA iTeos Therapeutics SA Pharmaceuticals: MajorHealth Technology Engages in the discovery of immunomodulators for cancer therapy	Chairman	26/06/2018
Omnes Capital SAS /Venture/ Omnes Capital SAS /Venture/ Investment ManagersFinance Omnes-Venture is an active manager which aims to combine an industrial and strategic overview of their target sectors with operational support for investee companies and financial optimization of investments. The firm takes minority stakes in recently founded businesses with strong European and international potential, focusing on the electronics, software, telecoms, life sciences and web technology services sectors. Their investment policy draws on exclusive sources of deal flow, including the management team's personal networks and privileged links to incubator funds, start-up funds, research labs, fundraisers and Crdit Agricole group's proprietary networks. They typically invest between 2 and 10 million euros. Omnes-Venture partners with investee companies, taking seats on supervisory boards or the board of directors, while respecting investee management's independence. They contribute to the company's strategy and development opportunities, select candidates for key positions in investee companies, working to optimize their financial resources and source industrial and financial partnerships.	Private Equity Investor	31/03/2011
BioVex Ltd. BioVex Ltd. Miscellaneous Commercial ServicesCommercial Services Develops and commercializes biological treatments for cancer and infectious diseases	Director/Board Member	03/03/2011
Diatos SA Diatos SA Pharmaceuticals: MajorHealth Technology Develops innovative therapies for the treatment of cancer	Director/Board Member	14/09/2009
Xention Pharma Ltd. Xention Pharma Ltd. Pharmaceuticals: MajorHealth Technology Develops and researches drugs	Director/Board Member	31/12/2006

See the detail of Philippe M. R. Guinot's experience

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Philippe M. R. Guinot's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	13
Diatos SA Diatos SA Pharmaceuticals: MajorHealth Technology Develops innovative therapies for the treatment of cancer	Health Technology
BioVex, Inc. BioVex, Inc. Pharmaceuticals: MajorHealth Technology Develops vaccines for the treatment of cancer and the prevention of chronic infectious diseases	Health Technology
BioVex Group, Inc. BioVex Group, Inc. BiotechnologyHealth Technology Develops vaccines for the treatment of cancer and the prevention of chronic infectious diseases	Health Technology
Xention Pharma Ltd. Xention Pharma Ltd. Pharmaceuticals: MajorHealth Technology Develops and researches drugs	Health Technology
PanGenetics BV PanGenetics BV Miscellaneous Commercial ServicesCommercial Services Researches and develops antibody-based therapeutic products	Commercial Services
Beaufour Ipsen Pharma SAS Beaufour Ipsen Pharma SAS Pharmaceuticals: OtherHealth Technology Develops and manufactures pharmaceutical products	Health Technology
BioVex Ltd. BioVex Ltd. Miscellaneous Commercial ServicesCommercial Services Develops and commercializes biological treatments for cancer and infectious diseases	Commercial Services
Cytheris SA Cytheris SA Pharmaceuticals: MajorHealth Technology Develops and manufactures drugs for immune modulation	Health Technology
METabolic EXplorer SA METabolic EXplorer SA Chemicals: SpecialtyProcess Industries Engages in development, production and commercialization of bioprocesses, producing functional ingredients applied in cosmetics, animal nutrition & biopolymers	Process Industries
Omnes Capital SAS /Venture/ Omnes Capital SAS /Venture/ Investment ManagersFinance Omnes-Venture is an active manager which aims to combine an industrial and strategic overview of their target sectors with operational support for investee companies and financial optimization of investments. The firm takes minority stakes in recently founded businesses with strong European and international potential, focusing on the electronics, software, telecoms, life sciences and web technology services sectors. Their investment policy draws on exclusive sources of deal flow, including the management team's personal networks and privileged links to incubator funds, start-up funds, research labs, fundraisers and Crdit Agricole group's proprietary networks. They typically invest between 2 and 10 million euros. Omnes-Venture partners with investee companies, taking seats on supervisory boards or the board of directors, while respecting investee management's independence. They contribute to the company's strategy and development opportunities, select candidates for key positions in investee companies, working to optimize their financial resources and source industrial and financial partnerships.	Finance
Amsterdam Molecular Therapeutics (AMT) Holding NV Amsterdam Molecular Therapeutics (AMT) Holding NV Miscellaneous Commercial ServicesCommercial Services Specializes in human gene therapy for metabolic disorders and ocular diseases	Commercial Services
Era Biotech SA Era Biotech SA Miscellaneous Commercial ServicesCommercial Services Develops cell-based biomanufacturing technologies	Commercial Services
iTeos Therapeutics SA iTeos Therapeutics SA Pharmaceuticals: MajorHealth Technology Engages in the discovery of immunomodulators for cancer therapy	Health Technology